293 related articles for article (PubMed ID: 19604335)
1. Conjunctival effects of canine distemper virus-induced keratoconjunctivitis sicca.
de Almeida DE; Roveratti C; Brito FL; Godoy GS; Duque JC; Bechara GH; Laus JL
Vet Ophthalmol; 2009; 12(4):211-5. PubMed ID: 19604335
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
Moore CP; McHugh JB; Thorne JG; Phillips TE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
[TBL] [Abstract][Full Text] [Related]
3. The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study.
Nell B; Walde I; Billich A; Vit P; Meingassner JG
Vet Ophthalmol; 2005; 8(1):39-46. PubMed ID: 15644099
[TBL] [Abstract][Full Text] [Related]
4. Analysis of tear uptake by the Schirmer tear test strip in the canine eye.
Williams DL
Vet Ophthalmol; 2005; 8(5):325-30. PubMed ID: 16178843
[TBL] [Abstract][Full Text] [Related]
5. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
Berdoulay A; English RV; Nadelstein B
Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
[TBL] [Abstract][Full Text] [Related]
6. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
Fullard RJ; Kaswan RM; Bounous DI; Hirsh SG
J Am Optom Assoc; 1995 Jul; 66(7):397-404. PubMed ID: 7560726
[TBL] [Abstract][Full Text] [Related]
7. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Izci C; Celik I; Alkan F; Erol M; Sur E
Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of keratoconjunctivitis sicca in the dog.
Williams DL
Vet Clin North Am Small Anim Pract; 2008 Mar; 38(2):251-68, vi. PubMed ID: 18299006
[TBL] [Abstract][Full Text] [Related]
9. Nuclear parameters and chromatin remodeling in epithelial cells and lymphocytes from the palpebral conjunctiva of dogs with keratoconjunctivitis sicca.
Dos Santos DM; Aldrovani M; Filezio MR; Abreu TGM; Balthazar da Silveira CP; Cruz NRDN; Laus JL
Vet Ophthalmol; 2019 Jan; 22(1):39-49. PubMed ID: 29493861
[TBL] [Abstract][Full Text] [Related]
10. Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca.
Gilbard JP; Rossi SR; Gray KL; Hanninen LA; Kenyon KR
Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):374-8. PubMed ID: 3343094
[TBL] [Abstract][Full Text] [Related]
11. Histopathology and immunohistochemistry of canine distemper virus-induced footpad hyperkeratosis (hard Pad disease) in dogs with natural canine distemper.
Koutinas AF; Baumgärtner W; Tontis D; Polizopoulou Z; Saridomichelakis MN; Lekkas S
Vet Pathol; 2004 Jan; 41(1):2-9. PubMed ID: 14715962
[TBL] [Abstract][Full Text] [Related]
12. A mouse model of keratoconjunctivitis sicca.
Dursun D; Wang M; Monroy D; Li DQ; Lokeshwar BL; Stern ME; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):632-8. PubMed ID: 11867577
[TBL] [Abstract][Full Text] [Related]
13. The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.
Murphy CJ; Bentley E; Miller PE; McIntyre K; Leatherberry G; Dubielzig R; Giuliano E; Moore CP; Phillips TE; Smith PB; Prescott E; Miller JM; Thomas P; Scagliotti R; Esson D; Gadek T; O'Neill CA
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3174-80. PubMed ID: 21330663
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
de Oliveira JK; Williams DL; Bollmann C; de Seabra NM; Bortolini M; Montiani-Ferreira F
Vet Ophthalmol; 2019 Sep; 22(5):633-643. PubMed ID: 30724448
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and phylogenetic analyses of canine distemper virus strain 007Lm, a new isolate in dogs.
Lan NT; Yamaguchi R; Furuya Y; Inomata A; Ngamkala S; Naganobu K; Kai K; Mochizuki M; Kobayashi Y; Uchida K; Tateyama S
Vet Microbiol; 2005 Oct; 110(3-4):197-207. PubMed ID: 16144749
[TBL] [Abstract][Full Text] [Related]
16. Canine neurogenic Keratoconjunctivitis sicca: 11 cases (2006-2010).
Matheis FL; Walser-Reinhardt L; Spiess BM
Vet Ophthalmol; 2012 Jul; 15(4):288-90. PubMed ID: 22051024
[TBL] [Abstract][Full Text] [Related]
17. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I; Szadkowski M
Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of reduction of virus release and cell-cell fusion in persistent canine distemper virus infection.
Meertens N; Stoffel MH; Cherpillod P; Wittek R; Vandevelde M; Zurbriggen A
Acta Neuropathol; 2003 Oct; 106(4):303-10. PubMed ID: 12827396
[TBL] [Abstract][Full Text] [Related]
19. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of canine distemper viral isolates from clinical cases of canine distemper in vaccinated dogs.
Lan NT; Yamaguchi R; Inomata A; Furuya Y; Uchida K; Sugano S; Tateyama S
Vet Microbiol; 2006 Jun; 115(1-3):32-42. PubMed ID: 16504421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
